Factorial Partners LLC Decreases Holdings in Centene Corporation $CNC

Factorial Partners LLC lowered its stake in Centene Corporation (NYSE:CNC) by 33.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,000 shares of the company’s stock after selling 23,000 shares during the period. Factorial Partners LLC’s holdings in Centene were worth $1,641,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Addison Advisors LLC boosted its holdings in shares of Centene by 455.6% in the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after purchasing an additional 606 shares during the period. Mowery & Schoenfeld Wealth Management LLC purchased a new position in Centene during the third quarter worth $27,000. WPG Advisers LLC raised its stake in shares of Centene by 44.5% in the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after acquiring an additional 282 shares during the period. Bogart Wealth LLC lifted its holdings in shares of Centene by 11,011.1% in the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after acquiring an additional 991 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC boosted its stake in shares of Centene by 54.9% during the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after purchasing an additional 390 shares during the period. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Centene Stock Performance

CNC stock opened at $43.21 on Friday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.08. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $66.03. The business has a 50-day moving average price of $42.44 and a 200 day moving average price of $36.94. The company has a market capitalization of $21.25 billion, a P/E ratio of -3.17, a PEG ratio of 0.96 and a beta of 0.48.

Centene (NYSE:CNC) last issued its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. The company had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. Centene’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.80 earnings per share. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, equities research analysts forecast that Centene Corporation will post 6.86 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Barclays set a $44.00 price objective on shares of Centene and gave the stock an “equal weight” rating in a research note on Tuesday, November 4th. Mizuho set a $47.00 price objective on Centene in a report on Friday, January 9th. JPMorgan Chase & Co. increased their target price on Centene from $38.00 to $45.00 and gave the stock a “neutral” rating in a research note on Thursday, January 22nd. Truist Financial upped their price target on shares of Centene from $45.00 to $47.00 and gave the stock a “buy” rating in a report on Monday, January 5th. Finally, Oppenheimer reiterated an “outperform” rating and set a $45.00 price objective on shares of Centene in a report on Thursday, October 30th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $41.88.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.